Search

Abstract Submission & Travel Grant Application

Late Poster Submission is now open Submit here 

Abstract ProcedurePlease note that the submission of an abstract constitutes a formal commitment by the presenting author to present the abstract (if accepted) orally or as a poster in the session at the…

Read more

1st joint EHA – Balkan Hematology Day, a meeting of true regional commitment

1st joint EHA – Balkan Hematology Day

Friday, October 11, 2019 | Pravets, Bulgaria

Meeting Chairs:

Prof Gert Ossenkoppele, Chair EHA Education Committee
Prof Gianluca Gaidano, Chair EHA Global Outreach Program Unit
Prof Margarita Guenova, Representative Balkan Societies

On Friday, October 11th the European Hematology Association (EHA)…

Read more

General Information

June 1, 2024
EHA2024 Congress platform opens

June 13-16, 2024
EHA2024 Madrid, Spain - In-person and live stream

Location 
IFEMA MADRID RECINTO FERIAL (Fairgrounds), Madrid, Spain

August 15, 2024
EHA2024 Congress platform closes

 
 

Scientific Program Committee (SPC) Chair
Prof Brian Huntly

Official Language
English  

EHA Congress Secretariat
INTERPLAN Congress, Meeting & Event Management…

Read more

What an EHA Kick-off Grant supports

Our EHA Kick-off Grant supports basic and translational lab-based research in hematology. Costs that can be supported by an EHA Kick-off Grant
Lab consumables. Max € 5,000 for equipment, if properly justified.

Read more

Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up

These Guidelines were developed by the European Hematology Association (EHA) and European Society for Medical Oncology (ESMO). The 2 societies nominated authors to write the guidelines as well as reviewers to comment on them.

Read more

Restoring Effective Anti-Tumor Response in Hodgkin Lymphoma with Nivolumab

Hodgkin Lymphoma typically affects young men and women in their 30s. Although it is highly curable with the current combination of chemo and radiation therapy, approximately 20% of patients will not be cured with first line regimens.

Read more